Authors:
FREUDENTHALER S
SCHREEB KH
KORNER T
GLEITER CH
Citation: S. Freudenthaler et al., ANGIOTENSIN-II INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 634-634
Authors:
FREUDENTHALER S
MEINEKE I
SCHREEB KH
GLEITER CH
Citation: S. Freudenthaler et al., PHARMACOKINETIC MODELING OF THE RENAL EXCRETION OF MEMANTINE - INFLUENCE OF URINE PH AND URINARY FLOW, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 668-668
Authors:
SCHREEB KH
FREUDENTHALER S
VORMFELDE SV
GUNDERTREMY U
GLEITER CH
Citation: Kh. Schreeb et al., COMPARATIVE BIOAVAILABILITY OF 2 VITAMIN-B1 PREPARATIONS - BENFOTIAMINE AND THIAMINE MONONITRATE, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 319-320
Authors:
GLEITER CH
BECKER T
BERGENER M
SCHREEB KH
FREUDENTHALER S
GUNDERTREMY U
Citation: Ch. Gleiter et al., FENOTEROL BUT NOT DOBUTAMINE INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 428-428
Authors:
SCHREEB KH
FREUDENTHALER S
GLEITER CH
GUNDERTREMY U
Citation: Kh. Schreeb et al., RELATIVE BIOAVAILABILITY OF THE VITAMIN-B1 ANALOG BENFOTHIAM, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 475-475
Authors:
VORMFELDE SV
GLEITER CH
FREUDENTHALER S
MUCK W
SCHMAGE N
KUHLMANN J
GUNDERTREMY U
Citation: Sv. Vormfelde et al., PHARMACOKINETICS OF SINGLE-DOSE CERIVASTATIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION, Atherosclerosis, 130, 1997, pp. 127-127
Authors:
GLEITER CH
BECKER T
SCHREEB KH
FREUDENTHALER S
GUNDERTREMY U
Citation: Ch. Gleiter et al., FENOTEROL BUT NOT DOBUTAMINE INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Clinical pharmacology and therapeutics, 61(6), 1997, pp. 669-676
Authors:
GLEITER CH
FREUDENTHALER S
DELABAR U
ECKARDT KU
MUHLBAUER B
GUNDERTREMY U
OSSWALD H
Citation: Ch. Gleiter et al., ERYTHROPOIETIN PRODUCTION IN HEALTHY-VOLUNTEERS SUBJECTED TO CONTROLLED HEMORRHAGE - EVIDENCE AGAINST A MAJOR ROLE FOR ADENOSINE, British journal of clinical pharmacology, 42(6), 1996, pp. 729-735
Authors:
LOSER SV
MEYER J
FREUDENTHALER S
SATTLER M
DESEL C
MEINEKE I
GUNDERTREMY U
Citation: Sv. Loser et al., MORPHINE-6-O-BETA-D-GLUCURONIDE BUT NOT MORPHINE-3-O-BETA-GLUCURONIDEBINDS TO MU-SPECIFIC, DELTA-SPECIFIC AND KAPPA-SPECIFIC OPIOID BINDING-SITES IN CEREBRAL MEMBRANES, Naunyn-Schmiedeberg's archives of pharmacology, 354(2), 1996, pp. 192-197
Authors:
VERHEGGEN R
FREUDENTHALER S
MEYERDULHEUER F
KAUMANN AJ
Citation: R. Verheggen et al., PARTICIPATION OF 5-HT1-LIKE AND 5-HT2A RECEPTORS IN THE CONTRACTION OF HUMAN TEMPORAL ARTERY BY 5-HYDROXYTRYPTAMINE AND RELATED DRUGS, British Journal of Pharmacology, 117(2), 1996, pp. 283-292